Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sight Sciences Inc
(NQ:
SGHT
)
5.790
-0.160 (-2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sight Sciences Inc
< Previous
1
2
3
4
5
6
Next >
Sight Sciences to Report First Quarter 2023 Financial Results on May 4, 2023
April 20, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences to Host Surgical Glaucoma Investor Symposium on Friday, May 5, 2023
April 13, 2023
The event will include presentations from leading glaucoma surgeons and remarks from the Sight Sciences executive management team
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer
April 03, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
A Preview Of Sight Sciences's Earnings
March 10, 2023
Via
Benzinga
Sight Sciences Defeats Invalidity Challenges Filed By Alcon and Ivantis In The U.S. Patent Office
March 30, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences Reports Fourth Quarter and Full Year 2022 Financial Results
March 13, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
March 09, 2023
The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures
From
Sight Sciences, Inc.
Via
GlobeNewswire
Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It
March 09, 2023
Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.
Via
Benzinga
Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
February 23, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
February 22, 2023
From
Sight Sciences, Inc.
Via
GlobeNewswire
3 Prime Healthcare Takeover Targets
February 14, 2023
These three companies are attractive targets for their potential.
Via
The Motley Fool
Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday
February 10, 2023
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Sight Sciences Announces 1,000th TearCare® Customer Installation
January 26, 2023
Over 1,000 Professional Eye Care Practices Have integrated the TearCare® System to Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD)
From
Sight Sciences, Inc.
Via
GlobeNewswire
Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday
January 10, 2023
U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
January 09, 2023
Company Also Announces CFO Transition
From
Sight Sciences, Inc.
Via
GlobeNewswire
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Dow Rises Over 300 Points; US Adds 223,000 Jobs In December
January 06, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023
January 06, 2023
Via
Benzinga
Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants
December 22, 2022
This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE).
Via
Benzinga
Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months
December 08, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Unity Software, Amazon, Doximity And Other Big Gainers From Friday
November 14, 2022
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 11, 2022
Gainers
Via
Benzinga
Dow Turns Higher; Nasdaq Jumps Over 200 Points
November 11, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 60 points on Friday.
Via
Benzinga
Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session
November 11, 2022
Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.
Via
Benzinga
Nasdaq Surges 100 Points; Crude Oil Rises Sharply
November 11, 2022
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining 100 points on Friday.
Via
Benzinga
US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points
November 11, 2022
U.S. stocks traded mixed this morning on Friday, after the Dow Jones jumped 1,200 points in the previous session.
Via
Benzinga
Sight Sciences Reports Third Quarter 2022 Financial Results
November 10, 2022
From
Sight Sciences, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 10, 2022
November 10, 2022
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.